Nat Med. 1997 May;3(5):505-9.

Cancer dormancy: opportunities for new therapeutic approaches.

Uhr JW, Scheuermann RH, Street NE, Vitetta ES.

Source

Cancer Immunobiology Center, University of Texas Southwestern Medical Center at Dallas 75235, USA.

PMID:: 9142117; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms

Publication Types

Review

MeSH Terms

LinkOut - more resources

Supplemental Content

Related citations

Review New clinical and experimental approaches for studying tumor dormancy: does tumor dormancy offer a therapeutic target? [APMIS. 2008]
Review New clinical and experimental approaches for studying tumor dormancy: does tumor dormancy offer a therapeutic target?
Goss P, Allan AL, Rodenhiser DI, Foster PJ, Chambers AF. APMIS. 2008 Jul-Aug; 116(7-8):552-68.
The problem of cancer dormancy: understanding the basic mechanisms and identifying therapeutic opportunities. [Cell Cycle. 2006]
The problem of cancer dormancy: understanding the basic mechanisms and identifying therapeutic opportunities.
Aguirre-Ghiso JA. Cell Cycle. 2006 Aug; 5(16):1740-3. Epub 2006 Aug 15.
[Establishment of animal model of breast cancer dormancy]. [Zhonghua Bing Li Xue Za Zhi. 2007]
[Establishment of animal model of breast cancer dormancy].
Su GY, Liu YQ, Ren LR, Liu XF, Gu B, Dong JH, Gao J. Zhonghua Bing Li Xue Za Zhi. 2007 Nov; 36(11):760-3.
Review Tumour dormancy: findings and hypotheses from clinical research on breast cancer. [Semin Cancer Biol. 2001]
Review Tumour dormancy: findings and hypotheses from clinical research on breast cancer.
Demicheli R. Semin Cancer Biol. 2001 Aug; 11(4):297-306.
Review Tumor dormancy and metastasis. [Adv Cancer Res. 2009]
Review Tumor dormancy and metastasis.
Hedley BD, Chambers AF. Adv Cancer Res. 2009; 102:67-101.

See reviews... See all...

Cited by 13 PubMed Central articles

Review Controversies in clinical cancer dormancy. [Proc Natl Acad Sci U S A. 2011]
Review Controversies in clinical cancer dormancy.
Uhr JW, Pantel K. Proc Natl Acad Sci U S A. 2011 Jul 26; 108(30):12396-400. Epub 2011 Jul 11.
Neurofibromatosis-1 heterozygosity increases microglia in a spatially and temporally restricted pattern relevant to mouse optic glioma formation and growth. [J Neuropathol Exp Neurol. 2011]
Neurofibromatosis-1 heterozygosity increases microglia in a spatially and temporally restricted pattern relevant to mouse optic glioma formation and growth.
Simmons GW, Pong WW, Emnett RJ, White CR, Gianino SM, Rodriguez FJ, Gutmann DH. J Neuropathol Exp Neurol. 2011 Jan; 70(1):51-62.
The sudden presentation and progression of overt cervical metastases following treatment of head and neck cancers. [Eur Arch Otorhinolaryngol. 2011]
The sudden presentation and progression of overt cervical metastases following treatment of head and neck cancers.
Woolgar JA, Ferlito A, Takes RP, Rodrigo JP, Silver CE, Devaney KO, Rinaldo A. Eur Arch Otorhinolaryngol. 2011 Jan; 268(1):1-4. Epub 2010 Nov 28.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Cancer dormancy: opportunities for new therapeutic approaches.
Cancer dormancy: opportunities for new therapeutic approaches.
Nat Med. 1997 May ;3(5):505-9.

PubMed
Hormone-induced refractoriness to mammary carcinogenesis in Wistar-Furth rats.
Hormone-induced refractoriness to mammary carcinogenesis in Wistar-Furth rats.
Carcinogenesis. 1998 Sep ;19(9):1573-81.

PubMed
Biochemical genetics of glutathione-S-transferase in man.
Biochemical genetics of glutathione-S-transferase in man.
Am J Hum Genet. 1981 Jan ;33(1):36-43.

PubMed
Adolescent diet and breast cancer in Utah.
Adolescent diet and breast cancer in Utah.
Cancer Res. 1989 Apr 15 ;49(8):2161-7.

PubMed
Drug resistance-associated marker Lrp for prediction of response to chemotherapy...
Drug resistance-associated marker Lrp for prediction of response to chemotherapy and prognoses in advanced ovarian carcinoma.
J Natl Cancer Inst. 1995 Aug 16 ;87(16):1230-7.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to:

Cancer dormancy: opportunities for new therapeutic approaches.

Source

Publication Types, MeSH Terms

Publication Types

MeSH Terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

Libraries

Supplemental Content

Related citations

Cited by 13 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information